1
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 29, 2001
DURAMED PHARMACEUTICALS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-15242 11-2590026
- --------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
7155 East Kemper Road, Cincinnati, Ohio 45249
---------------------------------------------
(Address of principal executive offices)
(513) 731-9900
----------------------------------------------------
(Registrant's telephone number, including area code)
2
INFORMATION TO BE INCLUDED IN THE REPORT
Items 1, 2, 3, 4, 6, 8 and 9 are not applicable and are omitted from this
Report.
Item 5. Other Events
A press release dated June 29, 2001 is attached hereto as Exhibit 99
and is incorporated herein by reference.
Item 7. Financial Statements Information and Exhibits
(a) Financial Statements of Businesses Acquired.
Not Applicable
(b) Pro Forma Financial Information.
Not Applicable
(c) Exhibits.
The following exhibits are filed with this Report on Form 8-K:
Regulation S-K
Exhibit No. Exhibit
----------- -------
99 Press release dated June 29, 2001
2
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: July 5, 2001 DURAMED PHARMACEUTICALS, INC.
By: /s/ Timothy J. Holt
------------------------------
Timothy J. Holt
Senior Vice President-Finance
and Administration
3